SAN FRANCISCO--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, debuts with $35 million in Series A financing led by Perceptive Xontogeny ...
It can be hard to keep track of all the great things individual people do in a fast-paced work environment on a day-to-day basis. Sending a quick thank-you note can be nice on a person-to-person level ...
BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data showing that its groundbreaking infectious disease test, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback